Skip to main content
An official website of the United States government

LMP1-specific chimeric antigen receptor-expressing T lymphocytes

A preparation of cytotoxic T lymphocytes (CTL) transfected with a chimeric antigen receptor (CAR) specifically recognizing the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1; LMP-1), with potential antineoplastic activity. Upon administration of the LMP1-specific CAR-expressing T lymphocytes to patients with LMP1-positive tumors, the CTLs specifically target and lyse tumor cells expressing LMP1, thereby inhibiting tumor cell proliferation. The tumor-associated antigen (TAA) LMP1 is expressed in various malignancies, including nasopharyngeal cancer and EBV-positive Hodgkin lymphoma.
Synonym:anti-LMP1 CAR T cells
LMP1-CAR-CTLs
LMP1-CAR-T cells
Search NCI's Drug Dictionary